Bill Gates recently stated that he views Pfizer (NYSE:PFE) as the leader in the coronavirus vaccine race. In a CNBC interview, he said, “The only vaccine that, if everything went perfectly, might seek the emergency use license by the end of October, would be Pfizer.” The Gates Foundation also owns shares of the big drugmaker.
It’s not surprising that the Bill & Melinda Gates Foundation also owns shares of BioNTech.
In 2015, the foundation committed to investing $52 million in CureVac (NASDAQ:CVAC).
The Gates Foundation was one of the lead investors in Vir Biotechnology (NASDAQ:VIR) at the biotech’s launch in late 2016 and early 2017.fool 4 Coronavirus Vaccine Stocks the Bill & Melinda Gates Foundation Is Betting On